Cargando…

Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells

INTRODUCTION: Mesenchymal stem cells (MSCs) can differentiate into various cell types and exhibit immunomodulatory and paracrine effects. The cryopreservation of umbilical cord tissue as a viable source of MSCs has great potential for the field of regenerative medicine. We previously demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rico, Jessica Patiño, Raffo, Diego, Romaso, Karen, Neira, Celeste, Sasso, Diego Fernandez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476929/
http://dx.doi.org/10.1093/stcltm/szad047.021
_version_ 1785101037329186816
author Rico, Jessica Patiño
Raffo, Diego
Romaso, Karen
Neira, Celeste
Sasso, Diego Fernandez
author_facet Rico, Jessica Patiño
Raffo, Diego
Romaso, Karen
Neira, Celeste
Sasso, Diego Fernandez
author_sort Rico, Jessica Patiño
collection PubMed
description INTRODUCTION: Mesenchymal stem cells (MSCs) can differentiate into various cell types and exhibit immunomodulatory and paracrine effects. The cryopreservation of umbilical cord tissue as a viable source of MSCs has great potential for the field of regenerative medicine. We previously demonstrated that it is feasible to cryopreserve umbilical cord tissue cut into small fragments measuring 2 to 5 mm in length and obtain viable cells by thawing them between 30 and 60 days after freezing. OBJECTIVES: We aim to assess the condition of previously frozen samples for periods exceeding one year and analyze the data obtained from the cryopreservation of new samples. METHODS: A total of 834 new samples were frozen with our protocol for umbilical cord tissue cryopreservation. These Samples were thawed after obtaining microbiological contamination results of each sample. Additionally, a group of 100 samples that have been kept frozen for at least one year were selected to be thawed to assess the viability of the tissue frozen for extended periods of time. All cultures were maintained and the days to reach confluence were registered. RESULTS: The microbial analysis of the group of 834 new samples showed similar microbial profile and risk factors to those previously reported by us, with higher contamination frequencies associated with vaginal delivery and samples obtained by less experienced personnel in the operating room. Moreover, similar to our previous reports, the most frequent microorganism detected in contaminated samples were Staphylococcus sp, Escherichia Coli, Enterococcus sp and Streptocuccus sp. The group of 100 samples that were kept frozen for a minimum period of one year were thawed to assess if we could obtain viable cells from them. All cell cultures obtained from the thawed tissue were successful, reaching confluence between days 18 and 23, which is consistent with our previously observed timings. DISCUSSION: New cryopreserved tissue samples, and samples frozen for more than one year had viable cells that can be expanded as a source of MSCs. Microbial profile of those samples showed association with sample collection conditions at the operating room indicating that proper training of the personnel is the key to reduce contamination rates.
format Online
Article
Text
id pubmed-10476929
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104769292023-09-05 Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells Rico, Jessica Patiño Raffo, Diego Romaso, Karen Neira, Celeste Sasso, Diego Fernandez Stem Cells Transl Med Perinatal Tissue Banking and Therapies (including MSCs) INTRODUCTION: Mesenchymal stem cells (MSCs) can differentiate into various cell types and exhibit immunomodulatory and paracrine effects. The cryopreservation of umbilical cord tissue as a viable source of MSCs has great potential for the field of regenerative medicine. We previously demonstrated that it is feasible to cryopreserve umbilical cord tissue cut into small fragments measuring 2 to 5 mm in length and obtain viable cells by thawing them between 30 and 60 days after freezing. OBJECTIVES: We aim to assess the condition of previously frozen samples for periods exceeding one year and analyze the data obtained from the cryopreservation of new samples. METHODS: A total of 834 new samples were frozen with our protocol for umbilical cord tissue cryopreservation. These Samples were thawed after obtaining microbiological contamination results of each sample. Additionally, a group of 100 samples that have been kept frozen for at least one year were selected to be thawed to assess the viability of the tissue frozen for extended periods of time. All cultures were maintained and the days to reach confluence were registered. RESULTS: The microbial analysis of the group of 834 new samples showed similar microbial profile and risk factors to those previously reported by us, with higher contamination frequencies associated with vaginal delivery and samples obtained by less experienced personnel in the operating room. Moreover, similar to our previous reports, the most frequent microorganism detected in contaminated samples were Staphylococcus sp, Escherichia Coli, Enterococcus sp and Streptocuccus sp. The group of 100 samples that were kept frozen for a minimum period of one year were thawed to assess if we could obtain viable cells from them. All cell cultures obtained from the thawed tissue were successful, reaching confluence between days 18 and 23, which is consistent with our previously observed timings. DISCUSSION: New cryopreserved tissue samples, and samples frozen for more than one year had viable cells that can be expanded as a source of MSCs. Microbial profile of those samples showed association with sample collection conditions at the operating room indicating that proper training of the personnel is the key to reduce contamination rates. Oxford University Press 2023-09-04 /pmc/articles/PMC10476929/ http://dx.doi.org/10.1093/stcltm/szad047.021 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Perinatal Tissue Banking and Therapies (including MSCs)
Rico, Jessica Patiño
Raffo, Diego
Romaso, Karen
Neira, Celeste
Sasso, Diego Fernandez
Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title_full Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title_fullStr Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title_full_unstemmed Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title_short Abstract 20 Long-Term Follow-Up of Cryopreserved Umbilical Cord Tissue as a Source of Mesenchymal Stem Cells
title_sort abstract 20 long-term follow-up of cryopreserved umbilical cord tissue as a source of mesenchymal stem cells
topic Perinatal Tissue Banking and Therapies (including MSCs)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476929/
http://dx.doi.org/10.1093/stcltm/szad047.021
work_keys_str_mv AT ricojessicapatino abstract20longtermfollowupofcryopreservedumbilicalcordtissueasasourceofmesenchymalstemcells
AT raffodiego abstract20longtermfollowupofcryopreservedumbilicalcordtissueasasourceofmesenchymalstemcells
AT romasokaren abstract20longtermfollowupofcryopreservedumbilicalcordtissueasasourceofmesenchymalstemcells
AT neiraceleste abstract20longtermfollowupofcryopreservedumbilicalcordtissueasasourceofmesenchymalstemcells
AT sassodiegofernandez abstract20longtermfollowupofcryopreservedumbilicalcordtissueasasourceofmesenchymalstemcells